1.
Daniels B, Pearson S-A. Opportunities for post-market surveillance of high cost medicines in Australia: Observing trastuzumab-treated women from early through late stage HER2-positive breast cancer (HER2BC): IJPDS (2017) Issue 1, Vol 1:123, Proceedings of the IPDLN Conference (August 2016). IJPDS [Internet]. 2017 Apr. 18 [cited 2026 Oct. 23];1(1). Available from: https://ijpds.org/index.php/ijpds/article/view/142